← Eichor
Study identifier: NCT06154356 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Action Observation and Motor Imagery Therapy in Parkinson's Disease

Condition: Parkinson's Disease  ·  Sponsor: Karamanoğlu Mehmetbey University

PhaseNA
Planned participants54
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind. The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.

This description comes directly from the study's public registry record.

Talk to the study team

Yurdagul Bahran Mustu, MD.  ·  +90 506 209 76 72  ·  yurdagulbahran@gmail.com

Aynur Basaran, MD, Prof.  ·  aynurbasaran@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Karaman Training and Research HospitalKaraman, Karaman, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06154356